Skip to main content
. 2007;9(Suppl 1):3–35. doi: 10.1080/16515320701258853
10:00 – 12:00 p.m. ParallelFree Papers Session: Transplant (Las Vegas Rooms)
Free Papers (FP – 05) Transplant
Abstract Number 140 – 149
140.) Role of primary resection for HCC under the era of liver transplantation
Toshiya Kamiyama, Kazuaki Nakanishi, MD, PhD, Hirofumi Kamachi, MD, PhD, Hideki Yokoo, MD, PhD, Munenori Tahara, MD, PhD, Hirofumi Toi, MD, PhD, Kenichiro Yamashita, MD, PhD, Masahiko Taniguchi, MD, PhD, Tomomi Suzuki, MD, PhD, Tsuyoshi Shimamura, MD, PhD, Hiroyuki Furukawa, MD, PhD, Michiaki Matsushita, MD, PhD, Satoru Todo, MD, PhD, Hokkaido University, Sapporo, Japan.
141.) Improved Survival in Hepatocellular Carcinoma: Results of a Single Center Analysis of 501 Patients
David Kooby, MD, Vasili Egnatashvili, MD, Michael Graiser, PhD, Keith Delman, MD, William Wood, MD, Charles Staley, MD, Emory University, Atlanta, GA.
142.) Tumor Size and Meld Score Predict Microvascular Invasion in Cirrhotic Patients with Hepatocellular Carcinoma
Swee H Teh, MD, B C Sheppard, MD, J Schwartz, MD, K G Billingsley, MD, S Cha, PhD, P S Kamath, MD, S L Orloff, MD, D M Nagorney, MD, Depart of Surgery, Oregon Health Sciences University, Portland, OR; Mayo Clinic, Rochester, MN.
143.) Outcomes Analysis for 280 Patients with Cholangiocarcinoma Treated with Liver Transplantation Over an 18-year Period
Natasha S Becker, MD, Joel Rodriguez, MD, Neal R Barshes, MD, MPH, Christine O'mahony, MD, John A Goss, MD, Thomas A Aloia, MD, Baylor College of Medicine, Houston, TX.
144.) Utilization of HTLV Positive Donor Livers For Transplantation
James V Guarrera, MD, Barbara Alkofer, MD, Jean C. Emond, MD, John F. Renz, MD, PhD, Columbia University, New York, NY.
145.) Liver Transplantation In Latin America
Eduardo De Santibañes, MD, PhD, Martín Palavecino, MD, Diego Fernández, MD, Victoria Ardiles, MD, Juan Mattera, MD, Juan Pekolj, MD, PhD, Miguel Ciardullo, MD, Hospital Italiano, Buenos Aires, Argentina.
146.) How to Balance the Risk for a Living Liver Donor-Or Is Death Always Preventable?
Burckhardt Ringe, MD, PhD, Humberto Soriano, MD, Ralph Petrucci, MD, William Meyers, MD, Drexel University College of Medicine, Philadelphia, PA.
147.) Laparoscopically-Assisted Right Lobe Donor Hepatectomy: Results and Comparison with Open Lobe Donor Hepatectomy
Alan J Koffron, MD, Robert Kung, Greg Auffenberg, Michael Abecassis, MD, Northwestern University Medical School, Chicago, IL.
148.) Venous reconstruction in living-donor hepatectomy
Atsushi Shimizu, MD, Yoshikazu Yasuda, MD, Masanobu Hyodo, MD, Taketo Fujiwara, MD, Yasunaru Sakuma, MD, Keisuke Yamashita, MD, Nobuyuki Hojo, MD, Hideo Chiba, MD, Makoto Ota, MD, Yoshito Nihei, MD, Hideo Nagai, MD, Jichi Medical School, Tochigi, Japan.
149.) The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation
Robert T. Russell, MD, Irene D. Feurer, PhD, Panarut Wisawatapnimit, C. Wright Pinson, MD, MBA, Vanderbilt University Medical Center, Nashville, TN.